Related references
Note: Only part of the references are listed.Ubiquitylation of cyclin C by HACE1 regulates cisplatin-associated sensitivity in gastric cancer
Hong-Yue Jiang et al.
CLINICAL AND TRANSLATIONAL MEDICINE (2022)
Global cancer statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries
Hyuna Sung et al.
CA-A CANCER JOURNAL FOR CLINICIANS (2021)
S-1 plus leucovorin and oxaliplatin versus S-1 plus cisplatin as first-line therapy in patients with advanced gastric cancer (SOLAR): a randomised, open-label, phase 3 trial
Yoon-Koo Kang et al.
LANCET ONCOLOGY (2020)
Skp2-mediated ubiquitination and mitochondrial localization of Akt drive tumor growth and chemoresistance to cisplatin
Xinfang Yu et al.
ONCOGENE (2019)
Polytherapy and Targeted Cancer Drug Resistance
Nilanjana Chatterjee et al.
TRENDS IN CANCER (2019)
Overexpression of HACE1 in gastric cancer inhibits tumor aggressiveness by impeding cell proliferation and migration
Ying-ling Chen et al.
CANCER MEDICINE (2018)
Ubiquitin ligases in oncogenic transformation and cancer therapy
Daniela Senft et al.
NATURE REVIEWS CANCER (2018)
Stress-Induced Nuclear-to-Cytoplasmic Translocation of Cyclin C Promotes Mitochondrial Fission in Yeast
Katrina F. Cooper et al.
DEVELOPMENTAL CELL (2014)
Identification of genes with correlated patterns of variations in DNA copy number and gene expression level in gastric cancer
Sanghwa Yang et al.
GENOMICS (2007)
Cyclin C/Cdk3 promotes Rb-dependent G0 exit
SJ Ren et al.
CELL (2004)